Literature DB >> 17410074

Selective antegrade cardioplegic perfusion complicated by left main stem dissection.

B P van Putte1, A Vink, P C De Bruin, J J A Defauw.   

Abstract

Selective antegrade coronary artery perfusion is a commonly used procedure to obtain myocardial preservation during cardiac surgery. This report describes a patient operated for severe aortic valve stenosis and insufficiency, mitral valve and tricuspid insufficiency. Cardioplegia was administered by selective antegrade coronary artery blood perfusion. Antegrade blood cardioplegia was complicated by dissection of the left coronary main stem. The dissection induced a myocardial infaction and the patient finally died due to heart failure.

Entities:  

Mesh：

Year:  2007        PMID： 17410074

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN： 0021-9509            Impact factor:   1.888


  4 in total

1.  Development of a new selective coronary perfusion cannula.

Authors:  Nobuo Kondo; Masaki Yamamoto; Kazuki Kihara; Seiichiro Wariishi; Takashi Fukutomi; Hideaki Nishimori; Kazumasa Orihashi; Tomotaka Takeshima; Kazuhiro Imakubo; Kazunori Aki
Journal:  J Artif Organs       Date:  2013-08-01       Impact factor: 1.731

2.  Left main coronary artery dissection after valve replacement: role of coronary computed tomographic angiography.

Authors:  Majid Kyavar; Hosseinali Bassiri; Anita Sadeghpour; Azin Alizadehasl; Hamidreza Pouraliakbar; Faranak Kargar
Journal:  Tex Heart Inst J       Date:  2012

3.  Successful recognition and percutaneous coronary intervention of delayed severe multiple coronary artery dissection caused by cardiac surgery: a case report.

Authors:  Dengshen Zhang; Jun Shi; Jianglong Hou; Yingqiang Guo
Journal:  BMC Surg       Date:  2019-08-23       Impact factor: 2.102

4.  Safety and Applicability of Continuous Retrograde Cardioplegia in Minimally Invasive Aortic Valve Replacement: New Approaches.

Authors:  Shunsuke Sato; Takashi Azami; Tatsuya Kawamoto; Kyozo Inoue; Kenji Okada
Journal:  Ann Thorac Cardiovasc Surg       Date:  2021-08-04       Impact factor: 1.520
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.